Item 5.07 Submission of Matters to a Vote of Security Holders.

On September 20, 2022, Caribou Biosciences, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The final results for each of the proposals submitted to a vote of the Company's stockholders at the Annual Meeting are set forth below. A more detailed description of each proposal is set forth in the Company's definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on August 11, 2022.

Proposal 1 - Election of Two Class I Directors

Each of the following nominees was elected to serve as a Class I director, to hold office until the Company's 2025 annual meeting of stockholders and until their respective successor is duly elected and qualified or until their earlier death, resignation, or removal.




    Nominee        Votes For    Votes Withheld   Broker Non-Votes
Scott Braunstein   24,250,029     9,247,428         8,203,175
Ran Zheng          27,580,406     5,917,051         8,203,175

Proposal 2 - Ratification of Selection of Independent Registered Public Accounting Firm

The stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, by the following votes:





Votes For    Votes Against   Votes Abstain
41,151,707      319,238         229,687

Item 9.01 Financial Statements and Exhibits.



(d)
Exhibit
Number                                           Description
104                 Cover Page Interactive Data File (embedded within the Inline XBRL
                    document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses